These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30680757)

  • 1. Altered profile of circulating microparticles in nonvalvular atrial fibrillation.
    Siwaponanan P; Keawvichit R; Udompunturak S; Hunnangkul S; Reesukumal K; Sukapirom K; Pattanapanyasat K; Krittayaphong R
    Clin Cardiol; 2019 Apr; 42(4):425-431. PubMed ID: 30680757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Levels of Platelets and Endothelial-Derived Microparticles in Patients With Non-Valvular Atrial Fibrillation During Rivaroxaban Therapy.
    Lenart-Migdalska A; Drabik L; Kaźnica-Wiatr M; Tomkiewicz-Pająk L; Podolec P; Olszowska M
    Clin Appl Thromb Hemost; 2021; 27():10760296211019465. PubMed ID: 34032122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated platelet microparticle levels in valvular atrial fibrillation.
    Azzam H; Zagloul M
    Hematology; 2009 Dec; 14(6):357-60. PubMed ID: 19941743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do atrial differences in endothelial damage, leukocyte and platelet activation, or tissue factor activity contribute to chamber-specific thrombogenic status in patients with atrial fibrillation?
    Jesel L; Arentz T; Herrera-Siklody C; Trenk D; Zobairi F; Abbas M; Weber R; Minners J; Toti F; Morel O
    J Cardiovasc Electrophysiol; 2014 Mar; 25(3):266-70. PubMed ID: 24172190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis.
    Suades R; Padró T; Alonso R; Mata P; Badimon L
    Thromb Haemost; 2015 Nov; 114(6):1310-21. PubMed ID: 26178021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy.
    Choudhury A; Chung I; Blann AD; Lip GYH
    Chest; 2007 Mar; 131(3):809-815. PubMed ID: 17356097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of circulating procoagulant microparticles in nonvalvular atrial fibrillation.
    Ederhy S; Di Angelantonio E; Mallat Z; Hugel B; Janower S; Meuleman C; Boccara F; Freyssinet JM; Tedgui A; Cohen A
    Am J Cardiol; 2007 Sep; 100(6):989-94. PubMed ID: 17826384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased blood cell phosphatidylserine exposure and circulating microparticles contribute to procoagulant activity after carotid artery stenting.
    Zhao L; Wu X; Si Y; Yao Z; Dong Z; Novakovic VA; Guo L; Tong D; Chen H; Bi Y; Kou J; Shi H; Tian Y; Hu S; Zhou J; Shi J
    J Neurosurg; 2017 Nov; 127(5):1041-1054. PubMed ID: 28009236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet function and microparticle levels in atrial fibrillation: Changes during the acute episode.
    Pourtau L; Sellal JM; Lacroix R; Poncelet P; Bernus O; Clofent-Sanchez G; Hocini M; Haïssaguerre M; Dignat-George F; Sacher F; Nurden P
    Int J Cardiol; 2017 Sep; 243():216-222. PubMed ID: 28747025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growing thrombi release increased levels of CD235a(+) microparticles and decreased levels of activated platelet-derived microparticles. Validation in ST-elevation myocardial infarction patients.
    Suades R; Padró T; Vilahur G; Martin-Yuste V; Sabaté M; Sans-Roselló J; Sionis A; Badimon L
    J Thromb Haemost; 2015 Oct; 13(10):1776-86. PubMed ID: 26239059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
    Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
    Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased concentrations of platelet- and endothelial-derived microparticles in patients with myocardial infarction and reduced renal function- a descriptive study.
    Mörtberg J; Lundwall K; Mobarrez F; Wallén H; Jacobson SH; Spaak J
    BMC Nephrol; 2019 Mar; 20(1):71. PubMed ID: 30823870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications and procoagulant activity of phosphatidylserine exposure of blood cells and microparticles in patients with atrial fibrillation treated with pulmonary vein isolation.
    Meng H; Kou J; Ma R; Ding W; Kou Y; Cao M; Dong Z; Bi Y; Thatte HS; Shi J
    Mol Med Rep; 2017 Dec; 16(6):8579-8588. PubMed ID: 29039531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of microparticles derived from monocytes, endothelial cells and platelets in the exacerbation of COPD.
    Tőkés-Füzesi M; Ruzsics I; Rideg O; Kustán P; Kovács GL; Molnár T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3749-3757. PubMed ID: 30532530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between renal function and circulating microparticles, soluble P-selectin and E-selectin levels in atrial fibrillation.
    Lau YC; Xiong Q; Blann AD; Lip GY
    J Thromb Thrombolysis; 2017 Jan; 43(1):18-23. PubMed ID: 27671694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques.
    Suades R; Padró T; Vilahur G; Badimon L
    Thromb Haemost; 2012 Dec; 108(6):1208-19. PubMed ID: 23138460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased microparticle levels in middle-aged and elderly patients with insomnia may be involved in the pathogenesis of arteriosclerosis.
    Xu B; Ma L; Zhang N; Guo W; Luo LM; Wang C; Jiang Y; Liu LG
    Int Angiol; 2020 Jun; 39(3):252-260. PubMed ID: 32052947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma microparticles in Alzheimer's disease: The role of vascular dysfunction.
    Hosseinzadeh S; Noroozian M; Mortaz E; Mousavizadeh K
    Metab Brain Dis; 2018 Feb; 33(1):293-299. PubMed ID: 29209923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study.
    Amabile N; Guérin AP; Tedgui A; Boulanger CM; London GM
    Nephrol Dial Transplant; 2012 May; 27(5):1873-80. PubMed ID: 22036944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension.
    Diehl P; Aleker M; Helbing T; Sossong V; Germann M; Sorichter S; Bode C; Moser M
    J Thromb Thrombolysis; 2011 Feb; 31(2):173-9. PubMed ID: 20680403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.